Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome

Luca Miele, Antonio Lanzone, Maurizio Pompili, Rosanna Apa, Francesca Sagnella, Daniela Martinez, Francesca Moro, Andrea Morciano, Consuelo Cefalo

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The objective of this study is to determine the ability of metformin treatment in reducing the prevalence of metabolic syndrome (MS) and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome (PCOS).
Original languageEnglish
Pages (from-to)520-527
Number of pages8
JournalClinical Endocrinology
Volume75
DOIs
Publication statusPublished - 2011

Keywords

  • Adult
  • Female
  • Humans
  • Hyperinsulinism
  • Hypoglycemic Agents
  • Liver
  • Metabolic Syndrome X
  • Metformin
  • Overweight
  • Polycystic Ovary Syndrome
  • Young Adult

Fingerprint

Dive into the research topics of 'Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome'. Together they form a unique fingerprint.

Cite this